Fenwick represented Aceragen on the deal, Morgan Lewis advised Idera Pharmaceuticals. Aceragen, a privately-held biotechnology company addressing rare, orphan pulmonary and rheumatic diseases for which there...
Idera Pharmaceuticals’ Acquisition of Aceragen
Adobe’s $20 Billion Acquisition of Figma
Wachtell Lipton and Skadden advised Adobe on the deal. Fenwick & West advised Sigma while Gunderson Dettmer represented clients Index Ventures, Kleiner Perkins and Greylock Partners....
Zuora’s US$44 Million Acquisition of Zephr Inc Limited
Foros acted as financial advisor and Fenwick & West and Slaughter and May acted as legal advisor to Zuora. Stifel acted as financial advisor and Cooley...
Snowflake’s Acquisition of Streamlit
Baker McKenzie advised Snowflake on the deal while Fenwick represented Streamlit. Snowflake executed the acquisition of Streamlit, a framework built to simplify and accelerate the creation of...
Sema4’s Acquisition of GeneDx
Fenwick & West advised Sema4 on the deal. Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, announced its agreement to acquire GeneDx, an...
Sanofi’s Pending Acquisition of Amunix
Fenwick & West advised Amunix on the deal, while Weil, Gotshal & Manges advised Sanofi. Amunix, an immuno-oncology company, announced its pending acquisition by Sanofi, a global...
Amwell’s Acquisition of Conversa Health
Fenwick advised Conversa Health, while Ropes & Gray advised Amwell in the transaction. Amwell® (NYSE: AMWL), a national telehealth leader, has signed definitive agreements to acquire SilverCloud Health,...